4 Dividend Stocks That Give You a Clean Taste

Published Mon, 16 Jan 2012 20:23 CET by DividendYields.org

Introduction
Since I like to take good care of my teeth, I use mouthwash after brushing. While gargling, I was annoyed that every time I screwed the cap back on the bottle of Listerine® (I drink from the cap, yes), a little bit of mouthwash dripped from the cap on the bottle and the shelf, making it all very sticky. The previous bottle of mouthwash I used was Elmex Sensitive. For some of you an unknown brand maybe, but they really did something very clever: they made a little drinking tube inside the cap! Lo and behold, no more mouthwash dripping out, no more sticky bottles!
What does this have to do with dividend investing? Well... nothing really. But it gave me the idea to take a look at the companies behind all those bottles of mouthwash and see how they're doing, dividend-wise. So here we go.

How to invest in a clean taste?
Since this website is about dividend investing, the focus will be on stocks paying out dividend. Luckily, most producers of mouthwash are well-known companies and listed on the New York Stock Exchange: Colgate Palmolive (NYSE: CL), GlaxoSmithKline (NYSE: GSK), Jonhson & Johnson (NYSE: JNJ) and Procter & Gamble (NYSE: PG). All companies except GlaxoSmithKline are also S&P 500 Dividend Aristocrats.

Colgate Palmolive
Colgate Palmolive is owner of the GABA Group, which produces Aronal, Elmex and Meridol mouth-/dental rinses in Therwil, Switzerland. Colgate Palmolive had a net income of USD 2.5 billion in the last 12 months and has paid uninterrupted dividends on its common stock since 1895 and increased payments to common shareholders every year for 48 years.

GlaxoSmithKline
GSK produces mouthwash under the name of Astring-O-Sol, made famous by model Joey Eastwood in the kissing booth TV commercial. GSK had a net income of GBP 3.3 billion (~USD 5 billion) in the last 12 months.
The graphs below show the Earnings Per Share (EPS) and Dividend Per Share of GSK.

GlaxoSmithKline EPS and Dividend per Share Graphs

Jonhson & Johnson
In 2006, Listerine® became a JNJ product with the acquiring of Pfizer Consumer Healthcare. Listerine® Antiseptic was created in 1879, making it the first-ever antiseptic mouthwash. JNJ is the world's sixth-largest consumer health company with a net income of USD 64 billion in the last 12 months. The JNJ stock has seen 49 consecutive years of dividend increases.

Procter & Gamble
Oral-B (since acquiring Gillette in 2005) and Scope are brands of mouthwash made by Procter & Gamble. P&G is the largest consumer goods company with a net income of USD 11.8 billion in 2011 and has paid uninterrupted dividends on its stock since 1890 and increased payments to shareholders every year for 54 years.

Name Dividend growth rate (5 years) EPS growth (5 years)
Colgate Palmolive 12.83% 12.17 USD
GlaxoSmithKline 8.12% -17.22 GBP
Jonhson & Johnson 10.60% 7.35 USD
Procter & Gamble 11.37% 10.18 USD


Disclosure: at the moment of writing, TopYields doesn't own any of the stocks mentioned.
Stock name Dividend Yield
Glaxosmithkline 5.09
Procter & Gamble 3.41
Johnson & Johnson 2.57
Colgate Palmolive 2.47

Articles featuring Glaxosmithkline (GSK):

First Quarterly Update - Steve's Dividend Portfolio And Strategy For Replacing My Salary With Dividend Income

Welcome to the First Quarterly update in my series for replacing my salary with dividend income. In the initial article, I outlined my portfolio strategy for replacing one of our salaries when my wife and I retire which is comprised of individual securities and ETFs. It's been three months since this article was released and I have some updates to share. The current state of the portfolio Individual Securities Quarter Month 1 Month 2 Month 3 Ticker Dividend... Read more

5%+ Dividend Yield Portfolio: Foreign Markets Disappointing You Again? (August 2018 Review)

Outlook Call it the pain of international diversification for 2018. With a significant divergence between US and international equities, the cost with holding DM and EM stocks has been significant. The differential between EM and US growth indices is over 25%. - Mark Rzepczynski There's just no way to sugar coat it, owning foreign stocks in 2018 (just like in 2017) has a real drag on returns. And there's plenty of pain to go around with both developed and emerging markets... Read more

5%+ Dividend Yield Portfolio: Sticking To The Plan (July 2018 Review)

Outlook "Nothing so undermines your financial judgement as the sight of your neighbor getting rich. - J.P. Morgan For fundamentals driven investors with a value tilt like me, July was likely a solid month with decent gains in holdings value. However, most value focused investors probably struggled to match the blazing +3.7% of the S&P 500. Despite the late month implosions of Facebook (FB) and Twitter (TWTR), this is still very much a growth/momentum driven market with large... Read more

GlaxoSmithKline: Dividend Safe For Now

We have been long GlaxoSmithKline (GSK) for many months now and our cost (excluding reinvested dividends) is around the $35.50 level. With shares now trading north of $41 per share, we still see upside so will be remaining long for the time being. It seemed at the time that shares were under pressure due to the viability or lack thereof of the dividend. Value and dividend growth investors have bought aggressively since the March lows which has resulted in a 14%+ increase in the share price... Read more

4 Safe Blue Chips With 5%+ Dividend Yields

With the S&P 500 Index at record highs, the average dividend yield in the S&P 500 is under 2%. In addition, interest rates still relatively low. As a result, investment income is hard to find today for investors who desire income, such as retirees. In order to find higher dividend yields in today's market, it seems that investors have to take outsized risks on stocks with sky-high yields, but also questionable fundamentals. But investors should remember that just because a stock... Read more